Image
Multidisciplinary Management of Bipolar Disorder Accelerating Diagnosis, Achieving Remission, and Encouraging Adherence

Michael E. Thase, MD, W. Clay Jackson, MD, DipTH, FAAFP, Susan Adams, PhD, RN, PMHMP, FAANP

This activity is jointly provided by Global Education Group and Integritas Communications.

This activity is supported by an independent educational grant from AstraZeneca.

Faculty

Susan Adams, PhD, PMHNP, FAANP
Professor of Nursing
Vanderbilt University School of Nursing
Nashville, Tennessee

W. Clay Jackson, MD, DipTh, FAAFP
Clinical Assistant Professor of Psychiatry
University of Tennessee College of Medicine
President and Medical Director, Comprehensive Primary Care
Medical Director, Methodist Alliance Hospice and Palliative Services
Memphis, Tennessee

Michael E. Thase, MD
Professor of Psychiatry
University of Pennsylvania, Perelman School of Medicine
Philadelphia, Pennsylvania

Target Audience

The educational design of this activity addresses the needs of psychiatrists, primary care providers, and other health care professionals involved in the diagnosis and management of patients with psychiatric disorders.

Program Description

This Clinical Research Updates™ expert roundtable was developed for psychiatrists, primary care providers, and other health care professionals involved in the management of patients with mental disorders.

Learning Objectives

Upon completion of this activity, participants should be able to:

  1. Identify individuals with bipolar disorder based on patient history, presenting symptoms, and the latest diagnostic criteria 
  2. Discuss the relative clinical profiles of agents that have shown efficacy for various phases of bipolar disorder 
  3. Individualize therapeutic regimens for bipolar disorder to maximize efficacy, safety, tolerability, and treatment adherence
  4. Counsel patients with bipolar disorder on the importance of self-management strategies and adherence to therapy

Physician Accreditation Statement

This activity has been planned and implemented in accordance with the Essential Areas and Policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Global Education Group (Global) and Integritas Communications. Global is accredited by the ACCME to provide continuing medical education for physicians.

Global Education Group designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. 

Nursing Continuing Education

Global Education Group is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s COA.

This educational activity for 1.0 contact hours is provided by Global Education Group. Nurses should claim only the credit commensurate with the extent of their participation in the activity.

Pharmacist Accreditation Statement

Global Education Group is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

Global Education Group designates this continuing education activity for 1.0 contact hour(s) (0.10 CEUs) of the Accreditation Council for Pharmacy Education. (Universal Activity Number - 0530-9999-15-050-H01-P)

This is a knowledge based activity.

Instructions for Obtaining Credit

In order to receive credit, participants must complete the preactivity questionnaire, postactivity questionnaire, and program evaluation. Participants must also score at least a 70% on the posttest.

For information about the accreditation of this program, please contact Global at 303-395-1782 or inquire@globaleducationgroup.com

System Requirements

PC
Microsoft Windows 2000 SE or above.
Flash Player Plugin (v7.0.1.9 or greater)
Internet Explorer (v8.0 or greater), Chrome, or Firefox

MAC
MAC OS 10+
Flash Player Plugin (v7.0.1.9 or greater)
Safari

Fee Information & Refund/Cancellation Policy

There is no fee for this educational activity.

Disclosure of Conflicts of Interest

Global requires instructors, planners, managers, and other individuals and their spouses/life partners who are in a position to control the content of this activity to disclose any real or apparent conflict of interest they may have as related to the content of this activity. All identified conflicts of interest are thoroughly vetted by Global for fair balance, scientific objectivity of studies mentioned in the materials or used as the basis for content, and appropriateness of patient care recommendations.

The faculty reported the following financial relationships or relationships to products or devices they or their spouses/life partners have with commercial interests related to the content of this CME activity:

Susan Adams, PhD, RN, PMHNP, FAANP has nothing to disclose.

W. Clay Jackson, MD, DipTh, FAAFP:  Honoraria: Forest Laboratories, Inc., Merck & Co, Inc., Otsuka Pharmaceutical Co., Ltd., Sunovion Pharmaceuticals Inc., Takeda Pharmaceutical Company Limited; Speakers Bureau: Pamlab, Inc.; Other: HalioHealth (equity ownership)

Michael E. Thase, MD: Consultant: Alkermes plc, Allergan, Inc., AstraZeneca, Bristol-Myers Squibb Company, Cerecor Inc., Eli Lilly and Company, Forest Labortories, Inc., Gerson Lehrman Group, Inc., GlaxoSmithKline, Guidepoint Global LLC, H. Lundbeck A/S, MedAvante, Inc., Merck & Co, Inc., moksha8 Pharmaceuticals Inc., Neuronetics, Inc., Novartis, Ortho-McNeil-Janssen Pharmaceuticals, Inc., Otsuka Pharmaceutical Co., Ltd, Pamlab, Inc., Pfizer Inc., Shire US Inc., Sunovion Pharmaceuticals Inc. Takeda Pharmaceutical Company Limited; Grant/Research: Agency for Healthcare Research and Quality, Alkermes plc, Forest Pharmaceuticals, Inc, National Institiute of Mental Health, Otsuka Pharmaceutical Co., Ltd., PharmaNeuroBoost, F. Hoffmann-La Roche Ltd; Stock Shareholder: Medavante, Inc.; Royalties: American Pyschiatric Foundation, Guilford Publications, Herald House, W.W. Norton & Company, Inc. 

The planners and managers reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME activity:

  • Rose O'Connor, PhD Nothing to disclose
  • Ashley Marostica, RN, MSN Nothing to disclose
  • Amanda Glazar, PhD Nothing to disclose
  • Andrea Funk Nothing to disclose

Disclosure of Unlabeled Use

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the Food and Drug Administration (FDA). Global Education Group (Global) and Integritas Communications do not recommend the use of any agent outside of the labeled indications. 

The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of any organization associated with this activity. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Disclaimer

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed in this activity should not be used by clinicians without evaluation of patient conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.

Click "Begin Activity" to acknowledge that you have reviewed the preamble information for this activity.

Begin Activity

expiration 05/27/2016

type Webcast